NCT04841083

Brief Summary

Study volunteers are asked to use the Allay Lamp routinely during the 6-week study period. A web based survey is provided when the Lamp is purchased for study volunteers to complete. A daily usage paper diary is sent with the lamp so that volunteers can keep track of the frequency and duration of lamp usage and any noticeable benefits. At the end of six weeks a second survey is sent to study volunteers to capture their perceptions of potential lamp benefits with respect to headache frequency and their experience of migraine specific symptoms.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
182

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 15, 2020

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 1, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 12, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 5, 2022

Completed
Last Updated

December 8, 2022

Status Verified

December 1, 2022

Enrollment Period

1.5 years

First QC Date

April 1, 2021

Last Update Submit

December 6, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in number of headache days per week

    Number of days with headache per week without and with using the Allay lamp

    Change from baseline at 6 weeks

  • Change in number of headache days per month

    Number of days with headache per month without and with using the Allay lamp

    Changes from baseline at weeks 3-6 of using the Allay lamp

  • Change in frequency of experiencing photophobia

    Assessing frequency of photophobia during days with headache as depicted by participants using the following options: (1)never, rarely, (2)less than half, (3)half or more, (4)nearly all the time.

    Changes from baseline at 6 weeks of using the Allay Lamp.

  • Change in headache severity

    Assessing headache severity while using the Allay lamp. Improvement is determined by the number of times participants answer Yes or NO in their daily diary.

    Changes from baseline at 6 weeks of using the Allay lamp

Study Arms (1)

Allay lamp (narrow band green light)

EXPERIMENTAL

Subjects who purchased the Allay Lamp are asked to document the effects of spending time in the narrow band of green light it emits, on their headache or any of its associated symptoms.

Device: Allay Lamp

Interventions

The Allay Lamp is a consumer product currently available and widely used in the US. It emits low intensity (1-10 lux) narrow band (20 nm) green light (peak wavelength 520 nm) that is marketed as non-irritating to users. In that context, it is not a medical device and does not require a 510(k).

Allay lamp (narrow band green light)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults with headaches or migraines.

You may not qualify if:

  • Not having headaches or migraines

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vendata Research

Chapel Hill, North Carolina, 27517, United States

Location

Related Publications (1)

  • Lipton RB, Melo-Carrillo A, Severs M, Reed M, Ashina S, Houle T, Burstein R. Narrow band green light effects on headache, photophobia, sleep, and anxiety among migraine patients: an open-label study conducted online using daily headache diary. Front Neurol. 2023 Oct 4;14:1282236. doi: 10.3389/fneur.2023.1282236. eCollection 2023.

MeSH Terms

Conditions

Migraine DisordersHeadache

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Managing Director

Study Record Dates

First Submitted

April 1, 2021

First Posted

April 12, 2021

Study Start

December 15, 2020

Primary Completion

June 15, 2022

Study Completion

December 5, 2022

Last Updated

December 8, 2022

Record last verified: 2022-12

Locations